MedTrace Logo

Evaluation of HQ® Matrix Medical Wound Dressing for Healing of Donor Site Wounds

NCT01993030 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2015-06-19

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the safety and effectiveness of HQ® Matrix Medical Wound Dressing for repair of donor site wounds. Half of participants will receive HQ® Matrix Medical Wound Dressing, while the other half will receive Sidaiyi® wound dressing.

Conditions

  • Donor Site Wound

Interventions

DEVICE

HQ® Matrix Medical Wound Dressing

DEVICE

Sidaiyi® wound dressing

Sponsors & Collaborators

  • Zhejiang Xingyue Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Li Qian, PhD · Second Xiangya Hospital of Central South University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01993030 on ClinicalTrials.gov